Trevena
Biopharmaceutical company developing novel G protein-biased ligands for the treatment of serious central nervous system disorders, including pain management. Publicly traded on NASDAQ (TRVN).
Website
https://www.trevena.comLocation
Chesterbrook, Pennsylvania, USA
Founded
2007
Investors
1
Categories
biotech, pharmaceuticals, pain-management, cns, public-company
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |